Enhanced Sensitivity to IL-2 Signaling Regulates the Clinical Responsiveness of IL-12-Primed CD8+ T Cells in a Melanoma Model
Journal of Immunology - United States
doi 10.4049/jimmunol.1003317
Full Text
Open PDFAbstract
Available in full text
Date
March 23, 2011
Authors
Publisher
The American Association of Immunologists